None listed
Conditions
Interventions
Intervention1: Cervical biopsy: Cervical biopsy will be taken in cases where either Pap or portable colposcope shows abnormal results and the results will be compared with the cytology and histopathol
Sponsors
Government Medical college and hospital Chandigarh
Eligibility
Inclusion criteria
Inclusion criteria: Sexually active women above the age of 30 (as recommended by WHO guidelines 2021)
Exclusion criteria
Exclusion criteria: Type 3 squamocolumnar junction Active bleeding per vaginum Frank growth on the cervix Post hysterectomy History of treatment of cancerous lesions Acute cervical infection or pelvic inflammatory disease (patients can be included after treatment)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the diagnostic accuracy of the Smartscope® for detection of pre-cancerous and cancerous lesions of the cervix using cytology or histopathology as the reference standardTimepoint: At first visit (when smartscope used), on collection of Pap report ,on collection of cervical biopsy report | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the Swede score calculated by the observer with the AI-based diagnosis keeping cytology and histopathology as the reference standardTimepoint: At first visit (when smartscope used), on collection of Pap report ,on collection of cervical biopsy report | — |
Countries
India
Contacts
Public ContactDr Bharti Goel
Government Medical college and Hospital Sector 32 Chandigarh
Outcome results
None listed